Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Yes, Gilead Did It Again
Seeking Alpha
Saturday, August 31, 2013 - 10:29am
tags:
Gilead, sofosbuvir
Arena Week 11 Sales Up Big
Seeking Alpha
Saturday, August 31, 2013 - 10:28am
tags:
Arena
Trade-Ideas: Arena Pharmaceuticals (ARNA) Is Today's "Dead Cat Bounce" Stock
The Street
Saturday, August 31, 2013 - 10:27am
tags:
Arena
GTx: 4 Reasons Why This $1 Biotech Stock Could Be Poised For A Big Rebound
Seeking Alpha
Saturday, August 31, 2013 - 10:26am
tags:
GTx
Voluntary Recall at Cubist Pharma
Yahoo/Zacks
Saturday, August 31, 2013 - 10:25am
tags:
Cubist Pharmaceuticals, Cubicin, recalls
Pfizer’s Pipeline Story Begins to Unravel
Yahoo/YCharts
Friday, August 30, 2013 - 12:32pm
tags:
Pfizer, Eliquis, Xalkori, Xeljanz, Inlyta, Elelyso
Teva reports top-line results from Phase III study of NUVIGIL
The Fly on the Wall
Friday, August 30, 2013 - 12:27pm
tags:
Teva, NUVIGIL, bipolar disorder
The Impact of a Failed Crohn's Disease Trial Study
Motley Fool
Friday, August 30, 2013 - 10:36am
tags:
Crohn's Disease, Vercirnon, ChemoCentryx, GSK
Will Amgen's Purchase Of Onyx Prove To Be A Smart Move?
Seeking Alpha
Friday, August 30, 2013 - 10:02am
tags:
Amgen, M&A, ONYX Pharmaceuticals
FDA clears 3D-printed skull fillers by Tissue Regeneration Systems
Mass Device
Friday, August 30, 2013 - 9:36am
tags:
FDA, Tissue Regenerations Systems, skull fillers, devices
Novartis' MS drug Gilenya tied to rare brain infection
Fierce Pharma
Friday, August 30, 2013 - 9:32am
tags:
Novartis, Gilenya, MS, multiple sclerosis, PML, FDA
3 Biotech Stocks Under $10 to Watch
TheStreet.com
Friday, August 30, 2013 - 9:31am
tags:
Athersys, BioDelivery Sciences, Neuralstem
China Drug Probe Leads to Tougher Market, Ipsen CEO Says
Bloomberg
Friday, August 30, 2013 - 9:28am
tags:
China, Ipsen
Cubist Receives Antitrust Clearance for Trius Purchase
Motley Fool
Friday, August 30, 2013 - 8:52am
tags:
Trius Therapeutics, Cubist Pharmaceuticals, M&A
ThromboGenics Plunges on Jetrea Sales Forecast
Bloomberg
Friday, August 30, 2013 - 8:49am
tags:
ThromboGenics, Jetrea, vitreomacular adhesion
New FDA Guidelines Hit This Company Hard
Motley Fool
Friday, August 30, 2013 - 8:47am
tags:
FDA, Allergan, generics, Restasis
Bristol Myers: A Leader In Cancer Care
Seeking Alpha
Friday, August 30, 2013 - 8:46am
tags:
Bristol-Myers Squibb, Merck, Gilead, Pfizer, Roche
Merrimack Progresses With MM-398
Yahoo/Zacks
Friday, August 30, 2013 - 8:45am
tags:
Merrimack Pharmaceuticals, MM-398, pancreatic cancer
3 Reasons Why Clinical Trials Fail
Motley Fool
Friday, August 30, 2013 - 8:44am
tags:
clinical trials
Stemline climbs as analyst forecasts $500M in sales for its most advanced cancer drug
Yahoo/AP
Thursday, August 29, 2013 - 5:09pm
tags:
Stemline, SL-401, acute myeloid leukemia, BPDCN

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.